We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Hikma Pharmaceuticals Plc | LSE:HIK | London | Ordinary Share | GB00B0LCW083 | ORD SHS 10P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 35.00 | 1.82% | 1,960.00 | 1,970.00 | 1,972.00 | 1,977.00 | 1,931.00 | 1,937.00 | 318,030 | 16:35:19 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 2.88B | 192M | 0.8685 | 22.68 | 4.36B |
From May 2019 to May 2024
By Ian Walker
Aldermore Group PLC (ALD.LN) said Wednesday that it will appoint Pat Butler as chairman once its 1.1 billion-pound ($1.47 billion) takeover by FirstRand Ltd. (FSR.JO) completes.
The specialist lender said Mr. Butler will become a non-executive director and chairman designate on Jan. 1, 2018. Danuta Gray will continue in her role as interim chairman until Mr. Butler's appointment, the company said, adding that she will then resume her role as senior independent director.
Aldermore said on Nov. 6 that it had accepted an offer of 313 pence a share from FirstRand. The deal was approved by the court and shareholders on Dec. 8.
Completion of the acquisition is still subject to certain conditions, and is expected in the first quarter of 2018.
Mr. Butler currently serves as an independent non-executive director of Bank of Ireland Group (BIRG.DB) and Bank of Ireland (U.K.), where he chairs the remuneration committee; of Hikma Pharmaceuticals (HIK.LN), where he is chairman of the audit committee; and of the Ardonagh Group, where he chairs the risk committee.
Write to Ian Walker at ian.walker@wsj.com; @IanWalk40289749
(END) Dow Jones Newswires
December 13, 2017 03:02 ET (08:02 GMT)
Copyright (c) 2017 Dow Jones & Company, Inc.
1 Year Hikma Pharmaceuticals Chart |
1 Month Hikma Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
